PK

Padma Kakrlapudi

Active Director Director DIN 08173078
DIN 08173078 First appointment Jul 2018 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Padma Kakrlapudi

Data last updated:

Padma Kakrlapudi is a Director at Yogitha Medicare Private Limited (since 2018). The company operates in Pharma.

DIN 08173078
Primary Designation Director
Industry Pharma
First Appointment 07 Jul 2018
Oldest Company Age 13 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Yogitha Medicare Private Limited U24230TG2013PTC086927
Director07 Jul 20182013Active

Directorship timeline

Open interactive timeline →
Yogitha Medicare Private Limited
Premium access

Shareholding and investment profile for Padma Kakrlapudi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Padma Kakrlapudi

Padma Kakrlapudi currently holds 1 directorship: Yogitha Medicare Private Limited (Director, since 07 Jul 2018).

Padma Kakrlapudi was first appointed on 07 Jul 2018 as Director at Yogitha Medicare Private Limited.

The current boards of Padma Kakrlapudi's companies include Anusha Kakarlapudi (Yogitha Medicare Private Limited), Atchutha Ramachandra Raju Kakarlapudi (Yogitha Medicare Private Limited), Palleti Praveen Kumar Reddy (Yogitha Medicare Private Limited), Venkata Lakshmana Kumar Peyyeti (Yogitha Medicare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available